Skip to main content
. 2023 Mar 9;13(6):1049. doi: 10.3390/diagnostics13061049

Table 1.

Demographics, lesion, and procedural characteristics.

Demographics N = 42 Subjects
   Female, No. (%) 23/42 (54.7)
   Age, mean (SD), y n = 42 68.89 (11.8)
   BMI, mean (SD), Kg/m2 n = 42 27.14(5.6)
   Chronic lung disease (COPD/ILD/Asthma) No. (%) 26/42 (61.9)
   History of cancer No. (%) 19/42 (45.2)
   History of lung cancer No. (%) 3/42 (7)
   Smoking history No. (%) 31/42 (73.8)
Lesion Properties
   Median Nodule size (mm) n = 42 (IQR) 12 (10–18)
      FDG avid No. (%) 27/32 84.4%
      Median SUV if FDG avid (mm) n = 27 (IQR) 4 (2.1–6.7)
   Bronchus sign, No. (%) 25/42 (59.2)
Nodule location, No. (%)
   Right upper lobe 19/42 (45.2)
      Left upper lobe 10 /42(23.8)
   Right middle lobe 4/42 (9.5)
   Right lower lobe 6/42 (14.3)
   Left lower lobe 3/42 (7.1)
   Lesion in central third of the lung 12/42 (28.6)
   Lesion in middle third of the lung 20/42 (47.6)
   Lesion in outer third of the lung 10/42 (23.8)
Nodule Radiologic features No. (%)
   Solid 37/42 (88)
   Semi Solid 2/42 (4.8)
   Ground glass 3/42 (7.1)
   Spiculated lesion border 10 /42 (23.8)
Procedure characteristics
   General anesthesia 42 (100%)
   Radial EBUS used during ENB 42 (100%)
   Endobronchial ultrasound (EBUS-TBNA) No. (%) 23/40 (57.5)
   Bronchioalveolar lavage No. (%)
   +Malignancy 4/42 (9.5%)
   +Infection Fungi 2/42 (4.7)
   Negative (normal cellular analysis) 36/42 (85%)
   Fluoroscopy used during ENB 42 (100%)
   ROSE used 42 (100%)
   Median number of passes (mm) n = 35 (IQR) 10 (7–2)

Data are presented as % (n/N), median (interquartile range), or mean (standard deviation). EBUS, endobronchial ultrasound. ENB electromagnetic navigation bronchoscopy. EBUS-TBNA, endobronchial ultrasound-guided transbronchial fine needle aspiration. ROSE, rapid on-site evaluation.